Atogepant and Migraine - podcast episode cover

Atogepant and Migraine

Oct 13, 202122 minEp. 103
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Atogepant (QULIPTA) was just approved by the FDA as a daily oral preventive treatment for migraine. Can we take gepants like Nurtec or Ubrelvy for our acute migraine attacks if we are taking atogepant? How effective is atogepant and what are the side effects? Does it work as well as the injected monoclonal antibodies for migraine prevention? On this episode, Lindsay Weitzel, PhD, asks migraine clinical trial expert Tim Smith, MD, all the hard questions.
For the best experience, listen in Metacast app for iOS or Android